# FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)

> **NCT05850078** · NA · COMPLETED · sponsor: **Freya Biosciences ApS** · enrollment: 97 (actual)

## Conditions studied

- Vaginal Flora Imbalance

## Interventions

- **OTHER:** FB101

## Key facts

- **NCT ID:** NCT05850078
- **Lead sponsor:** Freya Biosciences ApS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-18
- **Primary completion:** 2024-08-29
- **Final completion:** 2025-01-24
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05850078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05850078, "FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05850078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*